Vagal nerve stimulation in tuberous sclerosis complex patients

Area of Science:

• Pediatric Neurology
• Epileptology
• Neuroscience

Background:

• Tuberous sclerosis complex (TSC) is a genetic disorder often associated with medically refractory epilepsy.
• Vagal nerve stimulation (VNS) is an established treatment for refractory epilepsy, but its efficacy in TSC requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness and safety of intermittent vagal nerve stimulation (VNS) in pediatric patients with tuberous sclerosis complex (TSC) and drug-resistant epilepsy.
• To compare VNS outcomes in TSC patients with literature data, control VNS patients, and epilepsy surgery cohorts.

Main Methods:

• Retrospective, open-label, multicenter study involving ten pediatric patients with TSC and refractory epilepsy treated with VNS for at least six months.
• Comparison of seizure frequency reduction and adverse events with historical controls, registry data, and published surgical series.

Main Results:

• Nine out of ten TSC patients experienced at least a 50% reduction in seizure frequency with VNS.
• Half of the patients achieved a 90% or greater seizure frequency reduction; no adverse events were reported.
• VNS demonstrated improved seizure control compared to published VNS data and registry controls, but epilepsy surgery showed better outcomes.

Conclusions:

• Intermittent vagal nerve stimulation (VNS) is an effective and safe adjunctive therapy for managing refractory epilepsy in children with tuberous sclerosis complex (TSC).
• Epilepsy surgery presents a more promising option for achieving significant seizure control in this patient population.